Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activating a collaborative innate-adaptive immune response to control metastasis
Lijuan Sun, Tim Kees, Ana S. Almeida, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1361-1374.e9
Open Access | Times Cited: 186

Showing 1-25 of 186 citing articles:

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
Karin E. de Visser, Johanna A. Joyce
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 374-403
Open Access | Times Cited: 1539
Macrophages as tools and targets in cancer therapy
Alberto Mantovani, Paola Allavena, Federica Marchesi, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 799-820
Open Access | Times Cited: 1113
Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity
Tianhao Duan, Yang Du, Changsheng Xing, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 484
Clinical relevance of tumour-associated macrophages
Mikaël J. Pittet, Olivier Michielin, Denis Migliorini
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 402-421
Closed Access | Times Cited: 460
Tumor‐associated macrophages in liver cancer: From mechanisms to therapy
Kun Cheng, Ning Cai, Jinghan Zhu, et al.
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1112-1140
Open Access | Times Cited: 213
Myeloid cell-targeted therapies for solid tumours
Sangeeta Goswami, Swetha Anandhan, Deblina Raychaudhuri, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 2, pp. 106-120
Closed Access | Times Cited: 146
Targeting m6A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer
Yi Bao, Jianning Zhai, Huarong Chen, et al.
Gut (2023) Vol. 72, Iss. 8, pp. 1497-1509
Open Access | Times Cited: 124
Immunosenescence, aging and successful aging
Yunan Wang, Dong Chen, Yudian Han, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 112
Innate Immunity and Cancer Pathophysiology
Laura Maiorino, Juliane Daßler‐Plenker, Lijuan Sun, et al.
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 425-457
Open Access | Times Cited: 107
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 82
Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment
Xue‐Yan He, Yuan Gao, David Ng, et al.
Cancer Cell (2024) Vol. 42, Iss. 3, pp. 474-486.e12
Closed Access | Times Cited: 70
Tumor heterogeneity: preclinical models, emerging technologies, and future applications
Marco Proietto, Martina Crippa, C. Damiani, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 56
Spleen-selective co-delivery of mRNA and TLR4 agonist-loaded LNPs for synergistic immunostimulation and Th1 immune responses
Longze Pan, Lijing Zhang, Wenjing Deng, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 133-148
Closed Access | Times Cited: 45
25-Hydroxycholesterol regulates lysosome AMP kinase activation and metabolic reprogramming to educate immunosuppressive macrophages
Jun Xiao, Shuang Wang, Longlong Chen, et al.
Immunity (2024) Vol. 57, Iss. 5, pp. 1087-1104.e7
Closed Access | Times Cited: 37
Activating innate immune responses repolarizes hPSC-derived CAR macrophages to improve anti-tumor activity
Jun Shen, Shuzhen Lyu, Yingxi Xu, et al.
Cell stem cell (2024) Vol. 31, Iss. 7, pp. 1003-1019.e9
Closed Access | Times Cited: 18
Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies
Shuangli Zhu, Ming Yi, Yuze Wu, et al.
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 99
Nonresolving inflammation redux
Carl Nathan
Immunity (2022) Vol. 55, Iss. 4, pp. 592-605
Open Access | Times Cited: 64
DKK1 Promotes Tumor Immune Evasion and Impedes Anti–PD-1 Treatment by Inducing Immunosuppressive Macrophages in Gastric Cancer
Tao Shi, Yipeng Zhang, Yue Wang, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 12, pp. 1506-1524
Open Access | Times Cited: 64
Functional Immune Cell‐Derived Exosomes Engineered for the Trilogy of Radiotherapy Sensitization
Xiaotu Ma, Meinan Yao, Yu Gao, et al.
Advanced Science (2022) Vol. 9, Iss. 23
Open Access | Times Cited: 56
Flavonoids regulate tumor-associated macrophages – From structure-activity relationship to clinical potential (Review)
Qi Sun, Qi Liu, Xintong Zhou, et al.
Pharmacological Research (2022) Vol. 184, pp. 106419-106419
Closed Access | Times Cited: 53
Local scaffold-assisted delivery of immunotherapeutic agents for improved cancer immunotherapy
Qi Shang, Yabing Dong, Yun Su, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114308-114308
Closed Access | Times Cited: 50
pH-gated nanoparticles selectively regulate lysosomal function of tumour-associated macrophages for cancer immunotherapy
Mingmei Tang, Binlong Chen, Heming Xia, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 41
M1 polarization enhances the antitumor activity of chimeric antigen receptor macrophages in solid tumors
Yi Huo, Han Zhang, Longqi Sa, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 39
In Situ Reprogramming of Tumor‐Associated Macrophages with Internally and Externally Engineered Exosomes
Lingmin Zhang, Yinshan Lin, Songpei Li, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 11
Closed Access | Times Cited: 36
The generation, activation, and polarization of monocyte-derived macrophages in human malignancies
Paul Chaintreuil, Emeline Kerreneur, Maxence Bourgoin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top